Therapeutic opportunities within the DNA damage response

Pearl, Laurence H., Schierz, Amanda C., Ward, Simon E., Al-Lazikani, Bissan, Pearl, Frances M. G.·2015·Nature Reviews Cancer

Cited by (578)

Items 101–200 of 578

  1. Modification of DNA Checkpoints to Confer Aluminum Tolerance
    Thomas Eekhout, Paul B. Larsen, Lieven De Veylder · 2017 · Trends in Plant Science
  2. Inhibition of NADPH Oxidase-ROS Signal using Hyaluronic Acid Nanoparticles for Overcoming Radioresistance in Cancer Therapy
    Lei Zhu, Yi Zhao, Tongrui Liu, Minglong Chen, Wei Ping Qian, Bing‐Hua Jiang, Benjamin G. Barwick, Lumeng Zhang, Toncred Marya Styblo, Xiaoxian Li et al. · 2022 · ACS Nano
  3. Translational research in radiation-induced DNA damage signaling and repair
    Jac A. Nickoloff, Mary‐Keara Boss, Chris Allen, Susan Μ. LaRue · 2017 · Translational Cancer Research
  4. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer
    Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia et al. · 2022 · EBioMedicine
  5. Opportunities for Therapeutic Modulation of O-GlcNAc
    Steven S. Cheng, Alison C. Mody, Christina M. Woo · 2024 · Chemical Reviews
  6. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
    Yiling Situ, Liping Chung, Cheok Soon Lee, Vincent Ho · 2019 · International Journal of Molecular Sciences
  7. Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
    Erika Durinikova, Nicole Megan Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M.L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba et al. · 2022 · Clinical Cancer Research
  8. Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer
    Kyung‐Hee Chun, Jong Hoon Park, Siting Fan · 2017 · Advances in experimental medicine and biology
  9. DNA damage and repair measured by comet assay in cancer patients
    Pavel Vodička, Soňa Vodenková, Alena Opattová, Ľudmila Vodičková · 2019 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  10. Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
    Jaslyn Sian-Siu Soo, Char‐Hong Ng, Si Hoey Tan, Rozita Abdul Malik, Yew-Ching Teh, Boon-Shing Tan, Gwo Fuang Ho, Mee‐Hoong See, Nur Aishah Mohd Taib, Cheng Har Yip et al. · 2015 · APOPTOSIS
  11. DNA folds threaten genetic stability and can be leveraged for chemotherapy
    Joanna Zell, Francesco Rota Sperti, Sébastien Britton, David Monchaud · 2020 · RSC Chemical Biology
  12. Total Synthesis and Target Identification of the Curcusone Diterpenes
    Chengsen Cui, Brendan G. Dwyer, Chang Liu, Daniel Abegg, Zhong-Jian Cai, Dominic G. Hoch, Xianglin Yin, Nan Qiu, Jie‐Qing Liu, Alexander Adibekian et al. · 2021 · Journal of the American Chemical Society
  13. Metal nanoparticles for cancer therapy: Precision targeting of DNA damage
    Qian Chen, Chunyan Fang, Fan Xia, Qiyue Wang, Fangyuan Li, Daishun Ling · 2023 · Acta Pharmaceutica Sinica B
  14. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza‐Aghazadeh‐Attari, Caspian Ostadian, Amir Ata Saei, Ainaz Mihanfar, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Hossein Samadi Kafil, Bahman Yousefi, Maryam Majidinia · 2019 · DNA repair
  15. The whole-genome panorama of cancer drivers
    Radhakrishnan Sabarinathan, Oriol Pich, Iñigo Martincorena, Carlota Rubio-Pérez, Malene Juul, Jeremiah A. Wala, Steven E. Schumacher, Ofer Shapira, Nikos Sidiropoulos, Sebastian M. Waszak et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer
    Christopher D. Heinen · 2015 · DNA repair
  17. Xenopus egg extract: A powerful tool to study genome maintenance mechanisms
    Wouter S. Hoogenboom, Daisy Klein Douwel, Puck Knipscheer · 2017 · Developmental Biology
  18. Targeting DNA damage in SCLC
    Victoria Foy, Maximilian W. Schenk, Katie Baker, Fábio Gomes, Alice Lallo, Kristopher K. Frese, Martin David Forster, Caroline Dive, Fiona Helen Blackhall · 2017 · Lung Cancer
  19. Regulators in the DNA damage response
    Yunhua Liu, Yujing Li, Xiongbin Lu · 2016 · Archives of Biochemistry and Biophysics
  20. Harnessing DNA Replication Stress for Novel Cancer Therapy
    Huanbo Zhu, Umang Swami, Ranjan Preet, Jun Zhang · 2020 · Genes
  21. Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta
    Martin L. Stockley, Amanda Ferdinand, Giovanni Benedetti, Peter Blencowe, Susan M. Boyd, Mat Calder, Mark D. Charles, Lucy V. Edwardes, Tennyson Ekwuru, Harry Finch et al. · 2022 · Journal of Medicinal Chemistry
  22. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases
    Joseph Chi-Fung Ng, Jelmar Quist, Anita E. Grigoriadis, Michael H. Malim, Franca Fraternali · 2019 · Nucleic Acids Research
  23. Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity
    Uday Kiran Velagapudi, Marie-France Langelier, Cristina Delgado-Martín, Morgan E. Diolaiti, Sietske T. Bakker, Alan Ashworth, Bhargav A. Patel, Xuwei Shao, John M. Pascal, Tanaji T. Talele · 2019 · Journal of Medicinal Chemistry
  24. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
    Anne Ramsay Bowden, David A. Morales-Juarez, Matylda Sczaniecka-Clift, Maria Martin Agudo, Natalia Lukashchuk, John Christopher Thomas, Stephen P. Jackson · 2020 · eLife
  25. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity
    Xiaojie Xu, Zhongyi Fan, Chaoyang Liang, Ling Li, Lili Wang, Yingchun Liang, Jun Wu, Shaohong Chang, Zhifeng Yan, Zhaohui Lv et al. · 2017 · Nature Communications
  26. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
    Sitian Yang, Xiao Qi Wang · 2017 · BMC Cancer
  27. Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
    Ozan Alkan, Birgit Schoeberl, Millie Shah, Alexander Koshkaryev, Tim Heinemann, Daryl C. Drummond, Michael B. Yaffe, Andreas Raue · 2018 · Science Signaling
  28. Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly
    Elisa Fadda · 2015 · Computational and Structural Biotechnology Journal
  29. Cross-regulation between Notch signaling pathway and miRNA machinery in cancer
    Maryam Majidinia, Saber Ghazizadeh Darband, Mojtaba Kaviani, Seyed Mohammad Nabavi, Rana Jahanban‐Esfahlan, Bahman Yousefi · 2018 · DNA repair
  30. Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors
    Chenxi Wang, Zi-Lin Zhang, Qikun Yin, Jia-Li Tu, Jia-En Wang, Yao‐Hao Xu, Yong Rao, Tian‐Miao Ou, Shi‐Liang Huang, Ding Li et al. · 2020 · Journal of Medicinal Chemistry
  31. An RNA damage response network mediates the lethality of 5-FU in colorectal cancer
    Jung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George M. Eng, Erika D. Handly, Jesse Christopher Patterson, Ian Gordon Cannell, Lucía Suárez-López, Aaron M. Hosios et al. · 2024 · Cell Reports Medicine
  32. The role of cancer stem cells in tumor heterogeneity and resistance to therapy
    Christina Valbirk Konrad, Reshma Murali, Binitha Anu Varghese, Radhika Nair · 2016 · Canadian Journal of Physiology and Pharmacology
  33. Targeting of stress response pathways in the prevention and treatment of cancer
    Jaroslav Zelenka, Martina Koncošová, Tomáš Ruml · 2018 · Biotechnology Advances
  34. Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection
    Heeju Noh, Jason E. Shoemaker, Rudiyanto Gunawan · 2017 · Nucleic Acids Research
  35. Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
    Solip Park, Fran Supek, Ben Lehner · 2018 · Nature Communications
  36. Management and Treatment of Recurrent Epithelial Ovarian Cancer
    Shannon Dawn Armbruster, Robert Louis Coleman, Jose Alejandro Rauh‐Hain · 2018 · Hematology/Oncology Clinics of North America
  37. Mitochondrial DNA damage, repair, and replacement in cancer
    Pavel Vodička, Soňa Vodenková, Natalie Danesova, Ludmila Vodičková, Renata Zobalová, Kristýna Tomášová, Štěpána Boukalová, Michael V. Berridge, Jiřı́ Neužil · 2024 · Trends in cancer
  38. Improving survival in molecularly selected glioblastoma
    Roger Stupp, Rimas Vincas Lukas, Monika E. Hegi · 2019 · The Lancet
  39. Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
    Sang-Han Lee, Yoon‐Jin Lee · 2021 · Nutrition Research and Practice
  40. A Single‐Stranded DNA‐Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building Blocks
    Gabriele Bassi, Nicholas Favalli, Miriam Vuk, Marco Catalano, Adriano Luca Martinelli, Anika Trenner, Antônio Porro, Su Yang, Chuin Lean Tham, Mustafa Moroglu et al. · 2020 · Advanced Science
  41. Targeting the DNA Damage Response for Cancer Therapy
    Ruoxi Wang, Yating Sun, Chunshuang Li, Yaoyao Xue, Xueqing Ba · 2023 · International Journal of Molecular Sciences
  42. The DNA damage response pathway in normal hematopoiesis and malignancies
    Domenico Delia, Shuki Mizutani · 2017 · International Journal of Hematology
  43. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients
    Pavel Vodička, Markéta Urbanová, Pavol Makovický, Kristýna Tomášová, Michal Kroupa, Rudolf Štětina, Alena Opattová, Klara Kostovcikova, Anna Siskova, Michaela Schneiderová et al. · 2020 · International Journal of Molecular Sciences
  44. Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy
    Jac A. Nickoloff, Lynn Taylor, Neelam Sharma, Takamitsu A. Kato · 2021 · Cancer Drug Resistance
  45. Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology
    Martina Magni, Giacomo Buscemi, Laura Zannini · 2018 · Mutation Research/Reviews in Mutation Research
  46. DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome
    Kristýna Tomášová, Andrea Čumová, Karolína Šeborová, Josef Horak, Kamila Koucká, Ľudmila Vodičková, Radka Václavíková, Pavel Vodička · 2020 · Cancers
  47. Pan-Cancer Analysis Reveals Synergistic Effects of CDK4/6i and PARPi Combination Treatment in RB-Proficient and RB-Deficient Breast Cancer Cells
    Songyu Li, Yixiang Zhang, Na Wang, Rong Guo, Qiaoling Liu, Changsheng Lv, Jinguang Wang, Lina Wang, Qingkai Yang · 2018 · Cell Death and Disease
  48. Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM
    Jennifer Ma, Jeremy S. Setton, Luc G.T. Morris, Pedro Blecua, Christopher Andrew Barker, Benjamin H. Lok, Eric Jeffrey Sherman, Nora Katabi, Kathryn P. Beal, Ian Ganly et al. · 2016 · Oncotarget
  49. The DNA damage checkpoint: A tale from budding yeast
    Paolo Pizzul, Erika Casari, Marco Gnugnoli, Carlo Rinaldi, Flavio Corallo, Maria Pia Longhese · 2022 · Frontiers in Genetics
  50. Oxidative Damage Induces a Vacancy G-Quadruplex That Binds Guanine Metabolites: Solution Structure of a cGMP Fill-in Vacancy G-Quadruplex in the Oxidized BLM Gene Promoter
    Kai‐Bo Wang, Yushuang Liu, Yipu Li, Jonathan Dickerhoff, Jinzhu Li, Ming-Hua Yang, Danzhou Yang, Lingyi Kong · 2022 · Journal of the American Chemical Society
  51. DNA damage response signaling: A common link between cancer and cardiovascular diseases
    Sepideh Nikfarjam, Krishna Kumar Singh · 2022 · Cancer Medicine
  52. Cellular Responses to Widespread DNA Replication Stress
    Jac A. Nickoloff, Aruna Shanker Jaiswal, Neelam Sharma, Elizabeth A. Williamson, Manh Tien Tran, Dominic Arris, Ming Yang, Robert Hromas · 2023 · International Journal of Molecular Sciences
  53. TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1
    Mohammad Belayat Hossain, Rehnuma Shifat, David G. Johnson, Mark T. Bedford, Konrad R. Gabrusiewicz, Nahir Cortes‐Santiago, Xuemei Luo, Zhimin Lu, Ravesanker Ezhilarasan, Erik P. Sulman et al. · 2016 · Science Advances
  54. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
    Huang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen · 2022 · International Journal of Molecular Sciences
  55. Pentagalloylglucose disrupts the PALB2-BRCA2 interaction and potentiates tumor sensitivity to PARP inhibitor and radiotherapy
    Jie Zeng, Jichang Han, Zhaorui Liu, Yu Meng, Hao Li, Jianzhong Yu · 2022 · Cancer Letters
  56. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer
    Yuki Okawa, Yusuke Iwasaki, Todd A. Johnson, Nobutaka Ebata, Chihiro Inai, Mikiko Endo, Kazuhiro Maejima, Shota Sasagawa, Masashi Fujita, Koichi Matsuda et al. · 2022 · Journal of Hepatology
  57. Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells
    Huan Liu, Wenchao Zhang, Lijie Jin, Shasha Liu, Liying Liang, Yanfei Wei · 2023 · International Journal of Molecular Sciences
  58. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
    Chao Chen, Cai‐Jin Lin, Yu‐Chen Pei, Ding Ma, Li Liao, Si‐Yuan Li, Lei Fan, Gen‐Hong Di, Song‐Yang Wu, Xiyu Liu et al. · 2023 · Cell Discovery
  59. Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancer
    Habibollah Dadgar, Ali Pashazadeh, Nasim Norouzbeigi, Majid Assadi, Batool Albalooshi, Richard P. Baum, Akram Al‐Ibraheem, Mohamad Haidar, Mohsen Beheshti, Parham Geramifar et al. · 2025 · Theranostics
  60. Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis
    Jorge Luis Espinoza, Mika Minami · 2018 · Frontiers in Immunology
  61. A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice
    Paris Roidos, Stéphanie Sungalee, Salvatore Benfatto, Özdemirhan Serçin, Adrian M. Stütz, Amir Abdollahi, Jan Mauer, Frank T. Zenke, Jan O. Korbel, Balca R. Mardin · 2020 · Nature Communications
  62. MicroRNAs and Cancer Drug Resistance
    Bruno Costa Gomes, José Rueff, António Sebastião Rodrigues · 2016 · Methods in molecular biology
  63. Proteome Stability as a Key Factor of Genome Integrity
    Sentiljana Gumeni, Zoi Evangelakou, Vassilis G. Gorgoulis, Ioannis P. Trougakos · 2017 · International Journal of Molecular Sciences
  64. Fluorescent Probes of DNA Repair
    David L. Wilson, Eric T. Kool · 2017 · ACS Chemical Biology
  65. Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation
    Jan Stetka, Pavla Vyhlidalova, Lucie Lanikova, Pavla Kořalková, Ján Gurský, A. Hlusi, Patrik Flódr, Soňa Hubáčková, Jiří Bártek, Zdeněk Hodný et al. · 2019 · Oncogene
  66. Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
    Jin‐Xue He, Meng Wang, Xia‐Juan Huan, Chuan‐Huizi Chen, Shanshan Song, Ying-Qing Wang, Xue-Mei Liao, Cun Tan, Qian He, Linjiang Tong et al. · 2016 · Oncotarget
  67. CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions
    Dan Su, Xu Feng, Medina Colic, Yunfei Wang, Chunchao Zhang, Chao Wang, Mengfan Tang, Traver Hart, Junjie Chen · 2020 · DNA repair
  68. Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data
    Elodie Chartron, Charles G. Theillet, Séverine Guiu, William Jacot · 2018 · Critical Reviews in Oncology/Hematology
  69. Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer
    Yongchen Ma, Jing Zhu, Shanwen Chen, Ju Ma, Xiaoqian Zhang, Sixia Huang, Jianwen Hu, Taohua Yue, Junling Zhang, Pengyuan Wang et al. · 2019 · Cancer Cell International
  70. DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
    Ola Rominiyi, Spencer James Collis · 2021 · Molecular Oncology
  71. Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening
    Francesca Ester Morreale, Alessio Bortoluzzi, Viduth K. Chaugule, Connor Arkinson, Helen Walden, Alessio Ciulli · 2017 · Journal of Medicinal Chemistry
  72. BRCT domains of the DNA damage checkpoint proteins TOPBP1/Rad4 display distinct specificities for phosphopeptide ligands
    M.W. Day, Mathieu Rappas, Katie Ptasińska, Dominik Boos, Antony W. Oliver, Laurence H. Pearl · 2018 · eLife
  73. The impact of rare germline variants on human somatic mutation processes
    Mischan Vali-Pour, Solip Park, Jose Espinosa‐Carrasco, Daniel Ortiz-Martínez, Ben Lehner, Fran Supek · 2022 · Nature Communications
  74. Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2
    Péter Hornyák, Trevor Askwith, Sarah Walker, Emilia Komulainen, Michael Paradowski, Lewis E. Pennicott, Edward J. Bartlett, Nigel C. Brissett, Ali Raoof, Mandy Watson et al. · 2016 · Biochemical Journal
  75. Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage Response
    Wei Jiang, Quan Li, Zhengchun Zhu, Qin Wang, Jiaxiang Dou, Yingming Zhao, Weifu Lv, Fei Zhong, Yandan Yao, Guoqing Zhang et al. · 2018 · ACS Applied Materials & Interfaces
  76. G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes
    Hanne Leysen, Jaana van Gastel, Jhana O. Hendrickx, Paula Santos‐Otte, Bronwen Martin, Stuart R. Maudsley · 2018 · International Journal of Molecular Sciences
  77. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas
    Jing Wang, Ruiyu Li, Yangzhige He, Yuting Yi, Huanwen Wu, Zhiyong Liang · 2020 · Modern Pathology
  78. RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling
    Ling Wang, Xiaoke Chai, Run Wan, Hong Zhang, Cong Zhou, Xiang Lin, Maswikiti Ewetse Paul, Yumin Li · 2020 · Frontiers in Oncology · Retracted
  79. Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises
    Melissa M. Pham, Natalie Y.L. Ngoi, Guang Peng, David S.P. Tan, Timothy Anthony Yap · 2021 · Trends in cancer
  80. DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
    Jiawei Dai, Minlin Jiang, Kan He, Hao Wang, Peixin Chen, Haoyue Guo, Wencheng Zhao, Hui Juan Lu, Yayi He, Caicun Zhou · 2021 · Frontiers in Oncology
  81. Targeted photodynamic therapy in visible light using BODIPY-appended copper( ii ) complexes of a vitamin B 6 Schiff base
    Nandini Mukherjee, Santosh Podder, Koushambi Mitra, Shamik Majumdar, Dipankar Nandi, Akhil Ranjan Chakravarty · 2017 · Dalton Transactions
  82. Genetic vulnerabilities upon inhibition of DNA damage response
    Chao Wang, Mengfan Tang, Zhen Chen, Litong Nie, Siting Li, Yun Xiong, Klaudia Szymonowicz, Jeong-Min Park, Huimin Zhang, Xu Feng et al. · 2021 · Nucleic Acids Research
  83. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
    Salvatore Benfatto, Özdemirhan Serçin, Francesca R. Dejure, Amir Abdollahi, Frank T. Zenke, Balca R. Mardin · 2021 · Molecular Cancer
  84. Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy
    Miriana Cardano, Giacomo Buscemi, Laura Zannini · 2022 · iScience
  85. A multi-scale map of protein assemblies in the DNA damage response
    Anton Kratz, Minkyu Kim, Marcus R. Kelly, Fan Zheng, Christopher A. Koczor, Jianfeng Li, Keiichiro Ono, Yue Qin, Christopher Churas, Jing Chen et al. · 2023 · Cell Systems
  86. Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
    Paul McNulty, Richard Pilcher, Raviram Ramesh, Renata Necuiniate, Alis Hughes, REGISTRY Investigators of the European Huntington's Disease Network2, Daniel Mark Farewell, Peter Holmans, Lesley Jones, Raphael M. Bonelli et al. · 2018 · Journal of Huntington s Disease
  87. Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein
    Chen, Xiangrong, Ali, Yusuf I, Fisher, Charlotte EL, Arribas-Bosacoma, Raquel, Rajasekaran, Mohan B, Williams, Gareth, Walker, Sarah, Booth, Jessica R, Hudson, Jessica JR, Roe, S Mark et al. · 2021 · eLife
  88. Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation
    Xin Long, Anna Dai, Teng Huang, Wenhao Niu, Luoxia Liu, Hui Xu, Tao Yin, Tianan Jiang, Shuguo Sun, Ping Lei et al. · 2023 · ACS Nano
  89. Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical Implication
    Giuseppe Lamberti, Elisa Andrini, Monia Sisi, Alessandro Di Federico, Biagio Ricciuti · 2020 · Future Oncology
  90. Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers
    Shaoyang Zhang, Xiufeng Liu, Saleh Abdulmomen Ali Mohammed, Hui Li, Wanhua Cai, Wen xian Guan, Daiyun Liu, Yanli Wei, Dade Rong, Ying Fang et al. · 2021 · Autophagy
  91. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
    Ah‐Rong Nam, Mei Hua Jin, Ji Eun Park, Ju‐Hee Bang, Do‐Youn Oh, Yung‐Jue Bang · 2018 · Cancer Research and Treatment
  92. Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction
    Sofia Giacosa, Catherine Pillet, Irinka Séraudie, Laurent Guyon, Yann Wallez, Caroline Roelants, Christophe Battail, Bertrand Evrard, Frédéric Chalmel, Caroline Barette et al. · 2021 · Cancers
  93. Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy
    Kerry Silva McPherson, Dmitry M. Korzhnev · 2021 · RSC Chemical Biology
  94. ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination
    Doohyung Lee, Katja Apelt, Seong-Ok Lee, Hsin‐Ru Chan, Martijn S. Luijsterburg, Justin W. C. Leung, Kyle M. Miller · 2022 · Nucleic Acids Research
  95. Molecular and Cellular Functions of the Warsaw Breakage Syndrome DNA Helicase DDX11
    Francesca M. Pisani, Ettore Napolitano, Luisa M. R. Napolitano, Silvia Onesti · 2018 · Genes
  96. Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
    Rüveyda Dok, Marieke Bamps, Mary Glorieux, Peihua Zhao, Anna A. Sablina, Sandra Nuyts · 2019 · International Journal of Cancer
  97. Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
    Karam Khaddour, Lucas Maahs, Ana Maria Avila Rodriguez, Yazan Maamar, Sami Samaan, George Ansstas · 2021 · Cancers
  98. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome
    Hala Awada, François Paris, Claire Pecqueur · 2022 · Neuro-Oncology
  99. Transcriptional responses to DNA damage
    Silva, Erica, Ideker, Trey · 2019 · DNA repair
  100. Ubiquitination at the interface of tumor viruses and DNA damage responses
    Joseph M. Dybas, Christin Herrmann, Matthew D. Weitzman · 2018 · Current Opinion in Virology